Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 31.23 USD -1.79% Market Closed
Market Cap: 866.3m USD
Have any thoughts about
Castle Biosciences Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Castle Biosciences Inc

Current Assets 344.8m
Cash & Short-Term Investments 279.8m
Receivables 50.3m
Other Current Assets 14.7m
Non-Current Assets 169.8m
PP&E 56.3m
Intangibles 110.6m
Other Non-Current Assets 2.9m
Current Liabilities 44.3m
Accounts Payable 6.8m
Accrued Liabilities 34.5m
Other Current Liabilities 3m
Non-Current Liabilities 29.2m
Long-Term Debt 10.3m
Other Non-Current Liabilities 18.9m

Balance Sheet
Castle Biosciences Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1
5
99
410
330
123
99
Cash Equivalents
1
5
99
410
330
123
99
Short-Term Investments
0
0
0
0
0
136
144
Total Receivables
5
12
15
13
17
24
38
Accounts Receivables
5
12
15
13
17
24
38
Other Receivables
0
0
0
0
0
0
0
Inventory
0
1
1
2
2
4
8
Other Current Assets
1
1
2
5
5
6
6
Total Current Assets
7
18
117
430
354
292
296
PP&E Net
2
2
2
7
17
27
38
PP&E Gross
2
2
2
7
17
27
38
Accumulated Depreciation
1
1
1
2
3
8
8
Intangible Assets
0
0
0
0
89
116
107
Goodwill
0
0
0
0
0
11
11
Note Receivable
2
3
1
1
1
1
1
Other Long-Term Assets
0
0
0
2
2
1
1
Other Assets
0
0
0
0
0
11
11
Total Assets
10
N/A
22
+129%
120
+434%
439
+267%
463
+5%
447
-3%
453
+1%
Liabilities
Accounts Payable
1
2
2
2
3
5
10
Accrued Liabilities
3
5
8
12
21
29
34
Short-Term Debt
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
1
0
6
0
0
0
0
Other Current Liabilities
0
0
0
7
2
2
3
Total Current Liabilities
5
7
15
21
25
36
48
Long-Term Debt
18
25
19
0
0
0
0
Deferred Income Tax
0
0
0
0
1
0
0
Other Liabilities
1
1
0
3
25
12
14
Total Liabilities
24
N/A
33
+35%
35
+6%
24
-32%
51
+115%
48
-5%
62
+29%
Equity
Common Stock
36
47
0
0
0
0
0
Retained Earnings
51
58
52
63
94
161
218
Additional Paid In Capital
1
1
137
478
506
560
609
Other Equity
0
0
0
0
0
0
0
Total Equity
14
N/A
10
+29%
85
N/A
416
+388%
412
-1%
399
-3%
391
-2%
Total Liabilities & Equity
10
N/A
22
+129%
120
+434%
439
+267%
463
+5%
447
-3%
453
+1%
Shares Outstanding
Common Shares Outstanding
16
16
17
25
25
27
27

See Also

Discover More